Middle East And Africa Mea Radiotherapy Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
 Período de pronóstico |
2023 –2029 |
 Tamaño del mercado (año base) |
USD 157.48 Million |
 Tamaño del mercado (año de pronóstico) |
USD 220.32 Million |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
|
>Mercado de radioterapia en Oriente Medio y África, por tipo (radioterapia de haz externo, radioterapia interna, radioterapia sistémica/radiofármacos, otros), producto (radioterapia de haz externo, productos de radioterapia interna, software de radioterapia, radioterapia sistémica y otros), aplicación (cáncer de mama, cáncer de pulmón, cáncer de próstata, cáncer colorrectal, linfoma, cáncer de hígado, cáncer de tiroides, cáncer de cerebro, cáncer de cuello uterino, cáncer de columna vertebral, otros), usuario final (hospitales, centros de radioterapia, clínicas especializadas, otros), canal de distribución (licitación directa, ventas minoristas, otros), país (Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos, Egipto, Israel, Kuwait y resto de Oriente Medio y África), tendencias de la industria y pronóstico hasta 2029
Análisis y perspectivas del mercado: mercado de radioterapia en Oriente Medio y África
Se espera que el mercado de radioterapia de Oriente Medio y África gane crecimiento de mercado en el período de pronóstico de 2022 a 2029. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 4,5% en el período de pronóstico de 2022 a 2029 y se espera que alcance los USD 220,32 millones para 2029 desde USD 157,48 millones en 2021. La creciente prevalencia de la enfermedad del cáncer y la creciente adopción de dispositivos de radioterapia para el tratamiento del cáncer son los principales impulsores que se espera que impulsen la demanda del mercado en el período de pronóstico.
El tratamiento de radioterapia se utiliza principalmente para el tratamiento de enfermedades oncológicas mediante el uso de rayos X junto con formas similares de tecnología de radiación. En el tratamiento de radioterapia, se utilizan rayos de radiación de alta energía para dañar las células que causan cáncer y evitar que crezcan y se dividan. El tratamiento de radioterapia tiene numerosos tipos de beneficios para apuntar con precisión y localizar directamente el cáncer donde sea que se encuentre en el cuerpo. El procedimiento de radioterapia ha experimentado avances en términos de lanzamiento de nuevo software de planificación de tratamiento y modalidades de terapia avanzadas basadas en funciones, que requieren profesionales altamente capacitados y certificados para operar fácilmente estos productos y software.
La demanda de radioterapia ha aumentado en comparación con el año exacto con la creciente demanda de radioterapia junto con la creciente prevalencia de la enfermedad del cáncer en todo el mundo. Además, la demanda de radioterapia ha aumentado con la creciente preferencia por los procedimientos no quirúrgicos para el tratamiento del cáncer. Por ejemplo: según el Centro Nacional de Información Biotecnológica, el tratamiento del cáncer con radioterapia tiene el potencial de mejorar las tasas de curación en 3,5 millones de pacientes con cáncer, y también mejora el alivio paliativo para otros 3,5 millones de pacientes con cáncer, lo que aumenta en más de 14 millones de nuevos casos de cáncer cada año. Sin embargo, el alto costo del dispositivo y los paneles de radioterapia puede obstaculizar el uso de la radioterapia y se espera que desacelere el crecimiento del mercado de la radioterapia en el período de pronóstico.
Se espera que el aumento de los casos de cáncer en todo el mundo y la amplia aplicación de las radioterapias supongan una oportunidad para el mercado. Por otra parte, se espera que las estrictas regulaciones gubernamentales para los productos radiactivos supongan un desafío para los dispositivos médicos en el mercado de la radioterapia.
El informe sobre el mercado de radioterapia en Oriente Medio y África proporciona detalles sobre la participación de mercado, los nuevos desarrollos y el análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsas de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, contáctenos para obtener un resumen de analistas. Nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado de radioterapia en Oriente Medio y África
El mercado de radioterapia de Medio Oriente y África está segmentado en cinco segmentos notables que se basan en el tipo, el producto, la aplicación, el usuario final y el canal de distribución.
- Según el tipo, el mercado de radioterapia de Oriente Medio y África se segmenta en radioterapia de haz externo, radioterapia interna, radioterapia sistémica/radiofármacos y otros. En 2022, se espera que el segmento de radioterapia de haz externo domine el mercado debido a la alta adopción de radioterapia de haz externo para el tratamiento del cáncer de mama, cáncer de pulmón, cáncer de próstata, cáncer colorrectal, linfoma, cáncer de hígado, cáncer de tiroides, cáncer de cerebro, cáncer de cuello uterino y cáncer de columna, entre otros.
- En función del producto, el mercado de radioterapia de Oriente Medio y África se segmenta en radioterapia de haz externo, productos de radioterapia interna, software de radioterapia, radioterapia sistémica, entre otros. En 2022, se espera que el segmento de radioterapia de haz externo domine el mercado debido a la creciente demanda de dispositivos de radioterapia de haz externo, como LINAC, terapia de protones, cyberknife, gamma knife para el tratamiento del cáncer de mama, cáncer de pulmón, cáncer de próstata, cáncer colorrectal, linfoma, cáncer de hígado, cáncer de tiroides, cáncer de cerebro, cáncer de cuello uterino y cáncer de columna, entre otros.
- En función de la aplicación, el mercado de radioterapia de Oriente Medio y África se segmenta en cáncer de mama, cáncer de pulmón, cáncer de próstata, cáncer colorrectal, linfoma, cáncer de hígado, cáncer de tiroides, cáncer de cerebro, cáncer de cuello uterino, cáncer de columna vertebral y otros. En 2022, se espera que el segmento del cáncer de mama domine el mercado debido a la creciente prevalencia del cáncer de mama en todo el mundo. Además, el cáncer de mama es el cáncer más común en mujeres en todo el mundo. Además, según la Organización Mundial de la Salud, en 2019, se estima que se diagnosticaron 168.690 nuevos casos de cáncer de mama invasivo en África.
- On the basis of end user, the Middle East and Africa radiotherapy market is segmented into hospitals, radiation therapy centers, specialty clinics, and others. In 2022, the hospitals' segment is expected to dominate the market as the radiotherapy procedure is performed as an outpatient procedure in the hospital that normally takes less than 60 minutes and hospitals are one of the first contact points and the most trustable option for the patients in various countries for the treatment of cancer disease.
- On the basis of distribution channel, the Middle East and Africa radiotherapy market is segmented into direct tender, retail sales, and others. In 2022, the direct tender segment is expected to dominate the market as most hospitals, radiation therapy centers, specialty clinics, ambulatory surgical centers, and academic and research organizations prefer direct tender for the benefits of bulk buying, discounts, and ready availability of products.
Middle East and Africa Radiotherapy Market Country Level Analysis
The Middle East and Africa radiotherapy market is analyzed, and market size information is provided by type, product, application, end user, and distribution channel.
The countries covered in the Radiotherapy market report are South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait, and the rest of the Middle East and Africa.
South Africa is expected to dominate the Middle East and Africa radiotherapy market due to the presence of a large number of cancer cases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives By Manufacturers Is Creating New Opportunities For Players In The Radiotherapy Market
Middle East and Africa radiotherapy market also provide you with detailed market analysis for every country growth in the aesthetic industry with radiotherapy sales, the impact of advancement in radiotherapy, and changes in regulatory scenarios with their support for the Radiotherapy market. The data is available for the historical period 2011 to 2020.
Competitive Landscape and Radiotherapy Market Share Analysis
Panorama competitivo del mercado de radioterapia en Oriente Medio y África: proporcione detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, los sitios e instalaciones de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, las líneas de prueba de productos, las aprobaciones de productos, las patentes, la amplitud y la profundidad de los productos, el dominio de las aplicaciones y la curva de supervivencia de la tecnología. Los puntos de datos proporcionados anteriormente solo están relacionados con el enfoque de la empresa en relación con el mercado de radioterapia en Oriente Medio y África.
Algunos de los principales actores incluidos en el informe son Elekta AB (pub), RaySearch Laboratories, Brainlab, Koninklijke Philips NV, General Electric Company, Hitachi LTD., SIT - SIT Sordina IORT Technologies SpA, Sumitomo Heavy Industries, Ltd., Xoft, una subsidiaria de iCAD, Inc., ZEISS International, entre otros actores nacionales. Los analistas de DBMR comprenden las fortalezas competitivas y brindan un análisis competitivo para cada competidor por separado.
Numerosos lanzamientos de productos y acuerdos son también iniciados por empresas de todo el mundo, lo que también está acelerando el mercado de radioterapia en Oriente Medio y África.
Por ejemplo,
- En septiembre de 2019, Siemens Healthcare GmbH presentó dos sistemas de TC dedicados a la planificación de la radioterapia, Somatom go.Sim y Somatom go.Open Pro. El nuevo sistema hace que la planificación de la radioterapia sea más precisa. Con el lanzamiento de nuevos productos, la empresa ha mejorado su cartera de productos y ha generado ingresos adecuados en el mercado.
- En abril de 2019, Koninklijke Philips NV lanzó IntelliSpace Radiation Oncology, que se utiliza para acelerar el tiempo desde la derivación del paciente hasta el inicio del tratamiento. La solución se utiliza para gestionar la complejidad, mejorar la eficiencia y permitir la excelencia operativa en los departamentos de radioterapia. Con el lanzamiento de un nuevo producto, la empresa mejoró su cartera de productos y generó ingresos adecuados en el mercado.
La colaboración, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en el mercado de radioterapia, lo que también proporciona el beneficio para que la organización mejore su oferta de radioterapia.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA RADIOTHERAPY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S 5 FORCES
5 REGULATIONS
5.1 BRACHYTHERAPY DEVICES REGULATIONS:
5.2 USE OF SOURCES FOR MANUAL BRACHYTHERAPY.
5.3 BRACHYTHERAPY SOURCES ACCOUNTABILITY.
5.4 EUROPE MEDICAL AGENCY REGULATION
5.5 UK
5.6 INDIA:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING PREVALENCE OF CANCER DISEASE
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
6.2 RESTRAINTS
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.2.2 COMPLEX NATURE OF RADIOTHERAPY
6.2.3 HIGH COST OF RADIOTHERAPY PROCEDURE
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARDS CANCER TREATMENT
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
6.4 CHALLENGES
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
6.4.2 RISK OF RADIATION EXPOSURE
7 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA RADIOTHERAPY MARKET
7.1 IMPACT ANALYSIS ON DEMAND
7.2 CONCLUSION
8 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY TYPE
8.1 OVERVIEW
8.2 EXTERNAL-BEAM RADIATION THERAPY
8.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
8.2.2 PROTON BEAM THERAPY
8.2.3 STEREOTACTIC RADIATION THERAPY
8.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
8.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
8.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
8.2.7 OTHERS
8.3 INTERNAL RADIATION THERAPY
8.3.1 BRACHYTHERAPY
8.3.1.1 HIGH DOSE BRACHYTHERAPY
8.3.1.2 LOW DOSE BRACHYTHERAPY
8.3.2 SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
8.5 OTHERS
9 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY PRODUCT
9.1 OVERVIEW
9.2 EXTERNAL BEAM RADIATION THERAPY
9.2.1 LINAC
9.2.2 PROTON THERAPY
9.2.2.1 SYNCHROTRON
9.2.2.2 CYCLOTRON
9.2.3 CYBER KNIFE
9.2.4 GAMMA KNIFE
9.2.5 OTHERS
9.3 INTERNAL RADIOTHERAPY PRODUCTS
9.3.1 SEEDS
9.3.2 ELECTRONIC BRACHYTHERAPY
9.3.3 APPLICATORS
9.3.4 AFTERLOADERS
9.3.5 OTHERS
9.4 RADIOTHERAPY SOFTWARE
9.4.1 IMAGE GUIDING SOFTWARE
9.4.2 TREATMENT PLANNING SOFTWARE
9.4.3 PATIENT POSITIONING SOFTWARE
9.4.4 DOSAGE PLANNING SOFTWARE
9.4.5 OTHERS
9.5 SYSTEMIC RADIOTHERAPY
9.5.1 ALPHA EMITTERS
9.5.2 BETA EMITTERS
9.6 OTHERS
10 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 BREAST CANCER
10.3 LUNG CANCER
10.4 PROSTATE CANCER
10.5 COLORECTAL CANCER
10.6 LYMPHOMA
10.7 LIVER CANCER
10.8 THYROID CANCER
10.9 BRAIN CANCER
10.1 CERVICAL CANCER
10.11 SPINE CANCER
10.12 OTHERS
11 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 RADIATION THERAPY CENTERS
11.4 SPECIALTY CLINICS
11.5 OTHERS
12 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 OTHERS
13 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 UAE
13.1.4 EGYPT
13.1.5 ISRAEL
13.1.6 KUWAIT
13.1.7 REST OF MIDDLE EAST AND AFRICA
14 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 SIEMENS HEALTHCARE GMBH
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 ELEKTA AB (PUB)
16.2.1 COMPANY SNAPSHOT
16.2.2 RECENT FINANCIALS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 ACCURAY INCORPORATED
16.3.1 COMPANY SNAPSHOT
16.3.2 RECENT FINANCIALS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 GENERAL ELECTRIC COMPANY
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 IBA WORLDWIDE
16.5.1 COMPANY SNAPSHOT
16.5.2 RECENT FINANCIALS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG)
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.7 ADVANCED ONCOTHERAPY
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.8 ARIANE MEDICAL SYSTEMS LTD
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BRAINLAB
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 CANON MEDICAL SYSTEMS CORPORATION
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 CIVCO RADIOTHERAPY
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 ECKERT & ZIEGLER BEBIG
16.12.1 COMPANY SNAPSHOT
16.12.2 RECENT FINANCIALS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENT
16.13 HITACHI, LTD.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 INTRAOP MEDICAL, INC.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 ISORAY INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 KONINKLIJKE PHILIPS N.V.
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 MEVION MEDICAL SYSTEMS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 MIRADA MEDICAL LIMITED
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH)
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENT
16.2 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 P-CURE
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 PROTOM INTERNATIONAL
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 PROVISION HEALTHCARE
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
16.24 RAYSEARCH LABORATORIES
16.24.1 COMPANY SNAPSHOT
16.24.2 REVENUE ANALYSIS
16.24.3 PRODUCT PORTFOLIO
16.24.4 RECENT DEVELOPMENT
16.25 SIT - S.I.T. SORDINA IORT TECHNOLOGIES S.P.A.
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.26 SUMITOMO HEAVY INDUSTRIES, LTD.
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENT
16.27 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”)
16.27.1 COMPANY SNAPSHOT
16.27.2 RECENT FINANCIALS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
16.28 XOFT, A SUBSIDIARY OF ICAD, INC.
16.28.1 COMPANY SNAPSHOT
16.28.2 REVENUE ANALYSIS
16.28.3 PRODUCT PORTFOLIO
16.28.4 RECENT DEVELOPMENT
16.29 ZEISS INTERNATIONAL
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tablas
TABLE 1 MIDDLE EAST & AFRICA CANCER INCIDENCE (2018)
TABLE 2 MIDDLE EAST & AFRICA CANCER INCIDENCE (2018)
TABLE 3 MIDDLE EAST & AFRICA CANCER INCIDENCE (2018)
TABLE 4 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 5 PRODUCT CLASSIFICATION
TABLE 6 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA EXTERNAL BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA EXTERNAL BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA BREAST CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA LUNG CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA PROSTATE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA COLORECTAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA LYMPHOMA IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA LIVER CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA THYROID CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA BRAIN CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA CERVICAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA SPINE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA HOSPITALS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA RADIATION THERAPY CENTERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA DIRECT TENDER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA RETAIL SALES IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY COUNTRY, 2020-2029(USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 60 SOUTH AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 61 SOUTH AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 62 SOUTH AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 63 SOUTH AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 64 SOUTH AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 65 SOUTH AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 66 SOUTH AFRICA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 67 SOUTH AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 68 SOUTH AFRICA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 69 SOUTH AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 70 SOUTH AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 71 SOUTH AFRICA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 72 SOUTH AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 73 SAUDI ARABIA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 74 SAUDI ARABIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 75 SAUDI ARABIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 76 SAUDI ARABIA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 77 SAUDI ARABIA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 78 SAUDI ARABIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 79 SAUDI ARABIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 80 SAUDI ARABIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 81 SAUDI ARABIA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 82 SAUDI ARABIA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 83 SAUDI ARABIA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 84 SAUDI ARABIA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 85 SAUDI ARABIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 86 UAE RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 87 UAE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 88 UAE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 89 UAE BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 90 UAE RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 91 UAE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 92 UAE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 93 UAE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 94 UAE SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 95 UAE RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 96 UAE RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 97 UAE RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 98 UAE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 99 EGYPT RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 100 EGYPT EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 101 EGYPT INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 102 EGYPT BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 EGYPT RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 104 EGYPT EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 105 EGYPT PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 106 EGYPT INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 107 EGYPT SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 108 EGYPT RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 109 EGYPT RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 110 EGYPT RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 111 EGYPT RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 112 ISRAEL RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 113 ISRAEL EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 114 ISRAEL INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 115 ISRAEL BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 116 ISRAEL RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 117 ISRAEL EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 118 ISRAEL PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 119 ISRAEL INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 120 ISRAEL SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 121 ISRAEL RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 122 ISRAEL RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 123 ISRAEL RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 124 ISRAEL RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 125 KUWAIT RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 126 KUWAIT EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 127 KUWAIT INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 128 KUWAIT BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 129 KUWAIT RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 130 KUWAIT EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 131 KUWAIT PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 132 KUWAIT INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 133 KUWAIT SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 134 KUWAIT RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 135 KUWAIT RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 136 KUWAIT RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 137 KUWAIT RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 138 REST OF MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
Lista de figuras
FIGURE 1 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET : REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET : MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: MARKET APPLICATION TYPE COVERAGE GRID
FIGURE 11 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 12 GROWING PREVALENCE OF CANCER DISEASE AND NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA RADIOTHERAPY MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 EXTERNAL-BEAM RADIATION THERAPY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA RADIOTHERAPY MARKET IN 2022 & 2029
FIGURE 14 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA RADIOTHERAPY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA RADIOTHERAPY MARKET
FIGURE 16 CANCER DEATH RATES BY AGE GROUP (2017)
FIGURE 17 NUMBER OF NEW CANCER CASES IN 2018, ALL AGES
FIGURE 18 NUMBER OF NEW CASES IN 2018, IN MALES, ALL AGES
FIGURE 19 NUMBER OF NEW CASES IN 2018, IN FEMALES, ALL AGES
FIGURE 20 ESTIMATED LIFETIME CARE SPENDING
FIGURE 21 OUT OF POCKET COSTS DURING CANCER
FIGURE 22 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS
FIGURE 23 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY TYPE, 2021
FIGURE 24 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 26 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY TYPE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY PRODUCT, 2021
FIGURE 28 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 30 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY APPLICATION, 2021
FIGURE 32 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
FIGURE 33 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 34 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 35 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY END USER, 2021
FIGURE 36 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)
FIGURE 37 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 38 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY END USER, LIFELINE CURVE
FIGURE 39 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 40 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 41 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 42 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: SNAPSHOT (2021)
FIGURE 44 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY COUNTRY (2021)
FIGURE 45 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 46 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 47 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY TYPE (2022-2029)
FIGURE 48 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: COMPANY SHARE 2021 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
